1-3 of 3
Peter Sandy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of BET Protein Bromodomain Inhibition for the Treatment of Hematologic Malignancies

Robert Sims, PhD, Emmanuel Normant, PharmD, PhD, Peter Sandy, PhD, Jennifer Mertz, PhD, Barbara Bryant, PhD, Michael O'Meara, MS, Marie Green, PhD, Michael Cooper, MD, Jim Audia, PhD
Journal: Blood
Blood (2012) 120 (21): 1331.
https://doi.org/10.1182/blood.V120.21.1331.1331
Published: 2012
Journal Articles

High-Throughput RNA Interference Screening Identifies Synthetic Lethality Between Oncogenic KRAS Dependency and Suppression of STK33

Claudia Scholl, Stefan Frohling, Ian F. Dunn, David A. Barbie, Anna C. Schinzel, So Young Kim, Serena J. Silver, Lars Bullinger, Peter Sandy, Jesse S. Boehm, David E. Root, Tyler Jacks, William C. Hahn, D. Gary Gilliland
Journal: Blood
Blood (2008) 112 (11): 3806.
https://doi.org/10.1182/blood.V112.11.3806.3806
Published: 2008
Journal Articles

Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis

Raffaella Spagnuolo, Monica Corada, Fabrizio Orsenigo, Lucia Zanetta, Ulrich Deuschle, Peter Sandy, Claudio Schneider, Christopher J. Drake, Ferruccio Breviario, Elisabetta Dejana
Journal: Blood
Blood (2004) 103 (8): 3005–3012.
https://doi.org/10.1182/blood-2003-07-2459
Published: 2004